Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $43 and keeps an Equal Weight rating on the shares. After ...

In a report released today, Gena Wang from Barclays maintained a Hold rating on PTC Therapeutics (PTCT – Research Report), with a price target of $45.00. The company’s shares closed yesterday at ...

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene ... coats in ...

The production facility that prints The Providence Journal and the Boston Herald is closing, laying off 136 workers.

Tampa Bay forecasters say it’s too early to tell where the storm will go, but urged residents to keep an eye on forecasts.

“We need help,” he told NBC News this week, standing near the ruins of his business, Wedge Brewery. “We don’t need politics.” But a key source of federal aid may not be available any ...

The announcement left a lot unanswered. 4 min read Trump Picks Pete Hegseth, Veteran and Fox News Host, for Defense Secretary ...

The media industry has undergone an unprecedented transformation in the last quarter-century, with traditional news outlets ...

The ICC has launched a new logo for the 2025 ICC Champions Trophy. Pakistan is the confirmed host. India's participation is ...

Offering new tools like Magnetic Mask and the highly anticipated... at 18:02 PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy PTC Therapeutics, Inc. announced today the U.S.